Published in Hum Vaccin Immunother on June 11, 2013
HIV DNA Vaccine: Stepwise Improvements Make a Difference. Vaccines (Basel) (2014) 0.81
DNA vaccination by intradermal electroporation induces long-lasting immune responses in rhesus macaques. J Med Primatol (2014) 0.78
CCL17 combined with CCL19 as a nasal adjuvant enhances the immunogenicity of an anti-caries DNA vaccine in rodents. Acta Pharmacol Sin (2016) 0.75
Intra-cheek immunization as a novel vaccination route for therapeutic vaccines of head and neck squamous cell carcinomas using plasmo virus-like particles. Oncoimmunology (2016) 0.75
Coinjection of IL2 DNA enhances E7-specific antitumor immunity elicited by intravaginal therapeutic HPV DNA vaccination with electroporation. Gene Ther (2017) 0.75
DNA vaccines. Annu Rev Immunol (1997) 5.05
Intestinal IgA synthesis: regulation of front-line body defences. Nat Rev Immunol (2003) 2.62
Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J Immunol (2000) 2.54
Electroporation delivery of DNA vaccines: prospects for success. Curr Opin Immunol (2011) 2.25
DNA vaccines: an historical perspective and view to the future. Immunol Rev (2011) 2.02
Stochastic model for electric field-induced membrane pores. Electroporation. Biophys Chem (1984) 1.84
Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses. Sci Transl Med (2012) 1.84
Secretory IgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1. J Immunol (2001) 1.54
Control by pulse parameters of electric field-mediated gene transfer in mammalian cells. Biophys J (1994) 1.51
In vivo electroporation enhances the immunogenicity of hepatitis C virus nonstructural 3/4A DNA by increased local DNA uptake, protein expression, inflammation, and infiltration of CD3+ T cells. J Immunol (2007) 1.50
Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device. Gene Ther (2010) 1.35
Recruitment of antigen-presenting cells to the site of inoculation and augmentation of human immunodeficiency virus type 1 DNA vaccine immunogenicity by in vivo electroporation. J Virol (2008) 1.33
Model of cell electrofusion. Membrane electroporation, pore coalescence and percolation. Biophys Chem (1987) 1.29
Enhanced delivery of naked DNA to the skin by non-invasive in vivo electroporation. Biochim Biophys Acta (2002) 1.23
Regression of cervical intraepithelial neoplasia and loss of human papillomavirus (HPV) infection is associated with cell-mediated immune responses to an HPV type 16 E7 peptide. Cancer Epidemiol Biomarkers Prev (2002) 1.19
Optimization of cutaneous electrically mediated plasmid DNA delivery using novel electrode. Gene Ther (2006) 1.17
Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer. J Virol (2000) 1.13
Long-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization. Vaccine (2010) 1.13
A novel electroporation device for gene delivery in large animals and humans. Vaccine (2005) 1.09
Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the alpha-helix of gp41. AIDS (2002) 1.09
Use of DNA encoding influenza hemagglutinin as an avian influenza vaccine. DNA Cell Biol (1993) 1.07
DNA vaccines: crossing a line in the sand. Introduction to special issue. Vaccine (2008) 1.06
A novel prototype device for electroporation-enhanced DNA vaccine delivery simultaneously to both skin and muscle. Vaccine (2011) 1.04
Electrically mediated delivery of plasmid DNA to the skin, using a multielectrode array. Hum Gene Ther (2010) 1.02
CD8+ cytotoxic T cell therapy of cytomegalovirus and HIV infection. Curr Opin Immunol (1993) 1.01
Electroporation of skeletal muscle induces danger signal release and antigen-presenting cell recruitment independently of DNA vaccine administration. Expert Opin Biol Ther (2008) 1.00
Infectious human immunodeficiency virus can rapidly penetrate a tight human epithelial barrier by transcytosis in a process impaired by mucosal immunoglobulins. J Infect Dis (1999) 1.00
Evaluation of a novel non-penetrating electrode for use in DNA vaccination. PLoS One (2011) 0.96
Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model. Vaccine (2012) 0.93
Mucosal immunization with a DNA vaccine induces immune responses against HIV-1 at a mucosal site. Vaccine (1997) 0.93
Depth-targeted efficient gene delivery and expression in the skin by pulsed electric fields: an approach to gene therapy of skin aging and other diseases. Biochem Biophys Res Commun (1996) 0.93
Mucosal immunity and HIV-1 infection: applications for mucosal AIDS vaccine development. Curr Top Microbiol Immunol (2012) 0.89
Antigen presentation in the murine oral epithelium. Immunology (1996) 0.86
Effects of menstrual cycle on gene transfection through mouse vagina for DNA vaccine. Int J Pharm (2008) 0.86
Electroporation enhances immune responses and protection induced by a bovine viral diarrhea virus DNA vaccine in newborn calves with maternal antibodies. Vaccine (2010) 0.85
Tolerability of intramuscular and intradermal delivery by CELLECTRA(®) adaptive constant current electroporation device in healthy volunteers. Hum Vaccin Immunother (2013) 0.84
Enhancement of a human immunodeficiency virus env DNA vaccine using a novel polycationic nanoparticle formulation. Immunol Lett (2003) 0.81
Mucosal immunization with DNA encoding influenza hemagglutinin. Vaccine (1997) 0.78